Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma. A phase II study of the Gynecologic Oncology Group.
(Q33493236)
scientific article
scientific article
Language:
Current Data About
Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma. A phase II study of the Gynecologic Oncology Group.
other details
description | scientific article |
External Links
(P356) |
10.1097/00000421-199312000-00007
|
(P698) |
8256764
|